Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 3/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.31 |
| ▸ | ATM | Q13315 | 2/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | BACE1 | P56817 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7250719 | 0.78 | CA2 (0.36) | TSHRTDP1CA2CA1CYP3A4 | |
| SCHEMBL19105315 | 0.76 | TSHR (0.53) | TSHRTDP1HPGDCA2CA1 | |
| SCHEMBL28298417 | 0.76 | TSHR (0.50) | TSHRTDP1HPGDCA1CYP3A4 | |
| SCHEMBL10377995 | 0.76 | CA2 (0.35) | TSHRTDP1CA2CA1CYP3A4 | |
| SCHEMBL7959392 | 0.76 | NAAA (0.43) | TSHRCA2CA1CYP3A4MAPT | |
| SCHEMBL185251 | 0.76 | MAPT (0.42) | CA2CA1MAPT | |
| SCHEMBL12913888 | 0.75 | TSHR (0.51) | TSHRTDP1HPGDCA2CA1 | |
| SCHEMBL1685294 | 0.75 | TSHR (0.51) | TSHRTDP1HPGDCA2CA1 | |
| SCHEMBL11777423 | 0.74 | NAAA (0.46) | TSHRCA2CA1ACHEMAPT | |
| SCHEMBL9161765 | 0.74 | MAPT (0.44) | TSHRHPGDCA2CA1ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-3002139-A | — | — | None | — | — | JP | disclosed |
| US-6407229-B1 | ENZYME INHIBITOR | SANOCHEMIA PHARMAZEUTIKA AG (AT) | 2002-06-18 | — | — | US | disclosed |
| US-6369238-B1 | ENZYME INHIBITORS USED IN THE TREATMENT OF ALZHEIMER'S DISEASE | SANOCHEMIA PHARMAZEUTICA (AT) | 2002-04-09 | — | — | US | disclosed |
| US-6043359-A | REACTING A BENZALDEHYDE DERIVATIVE WITH A BENZENE ETHYLAMINE DERIVATIVE TO FORM A SCHIFF BASE, REDUCING THE SCHIFF BASE TO PRODUCE AN INTERMEDIATE, OXIDATIVELY CYCLYZATION, THEN STEREOSELECTIVE REDUCTION FORMS END PRODUCT | SANOCHEMIA PHARMAZEUTICA AKTIENGESELLSCHAFT (AT) | 2000-03-28 | — | — | US | disclosed |
| JP-H032139-A | PRODUCTION OF MEGASTIGMATRIENONE AND NOVEL COMPOUND CAPABLE OF BEING USED THEREIN | L GIVAUDAN & CIE SA | 1991-01-08 | — | — | JP | disclosed |